ARTIVA BIOTHERAPEUTICS, INC.

Profile

Company Names

ARTIVA BIOTHERAPEUTICS, INC.

Addresses

4747 EXECUTIVE DRIVE, SUITE 1150, SAN DIEGO, CA 92121

Phone Numbers

(858) 267-4467

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$163,441,865.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-02-22 
$120,000,001.00 
$120,000,001.00 
$0.00 
Equity 
1
2020-06-25 
$43,441,864.00 
$78,441,864.00 
$35,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED 
 
ASLAN 
EXECUTIVE OFFICER, DIRECTOR
ADVANCE MEDICAL, LTD.   |  FEMASYS INC   |  VIVIDION THERAPEUTICS, INC.   |  ARTIVA BIOTHERAPEUTICS, INC.
JENNIFER 
 
BUSH 
EXECUTIVE OFFICER
ARTIVA BIOTHERAPEUTICS, INC.
BRIAN 
 
DANIELS 
DIRECTOR
SPYRYX BIOSCIENCES, INC.   |  NOHLA THERAPEUTICS INC.   |  RARECYTE, INC.   |  IDEAYA BIOSCIENCES, INC.   |  CABALETTA BIO, INC.   |  ARTIVA BIOTHERAPEUTICS, INC.   |  SBARRO HOLDINGS, INC.
THOMAS 
J. 
FARRELL 
EXECUTIVE OFFICER, DIRECTOR
BELLICUM PHARMACEUTICALS, INC   |  ARTIVA BIOTHERAPEUTICS, INC.
PETER 
 
FLYNN 
EXECUTIVE OFFICER
PLUTONIC POWER CORP   |  OREXIGEN THERAPEUTICS, INC.   |  ARTIVA BIOTHERAPEUTICS, INC.
YONG-JUN 
 
HUH 
DIRECTOR
ARTIVA BIOTHERAPEUTICS, INC.
YU-KYEONG 
 
HWANG 
DIRECTOR
ARTIVA BIOTHERAPEUTICS, INC.
BONG 
 
KOH 
DIRECTOR
AVEXIS, INC.   |  VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.   |  RAYZEBIO, INC.   |  HYPOTHESIS STUDIO I, L.P.   |  ARTIVA BIOTHERAPEUTICS, INC.   |  KOHFOUNDERS FORMATION FUND, L.P.
JASON 
 
LITTEN 
EXECUTIVE OFFICER
ARTIVA BIOTHERAPEUTICS, INC.
LAURA 
 
STOPPEL 
DIRECTOR
ARTIVA BIOTHERAPEUTICS, INC.   |  INDAPTA THERAPEUTICS INC.   |  INFINANT HEALTH, INC.
ESTHER 
 
VAN DEN BOOM 
EXECUTIVE OFFICER
ARTIVA BIOTHERAPEUTICS, INC.   |  ELEUSIS HOLDINGS LTD   |  REACTIVE BIOSCIENCES INC.
YVONNE 
 
YAMANAKA 
DIRECTOR
ARTIVA BIOTHERAPEUTICS, INC.   |  IMMPACT BIO USA INC.   |  EYCONIS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-02-22 
2020-07-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#